Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Smaldone

Showing results (21-30 of 245) with videos related to

Pageof 25
Sort By:
Nature Reviews. Urology|March 15, 2017
Kidney cancer: Emerging guidelines for managing small renal massesBenjamin T Ristau, Marc C Smaldone
International Braz J Urol : Official Journal of the Brazilian Society of Urology|October 8, 2016
Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: NoBenjamin T Ristau, Marc C Smaldone
Urology|February 18, 2014
Editorial commentMarc C Smaldone, Robert G Uzzo
World Journal of Urology|May 13, 2008
Muscle derived stem cell therapy for stress urinary incontinenceMarc C Smaldone, Michael B Chancellor
Annals of Translational Medicine|October 29, 2019
Safety and delayed intervention rates of active surveillance for small renal masses in an elderly populationBrian T Kadow, Marc C Smaldone
Translational Andrology and Urology|June 23, 2021
Current controversies in minimally invasive urologic oncologyMarc C Smaldone, Jeffrey J Tomaszewski
Future Oncology (London, England)|October 14, 2011
Active surveillance: a potential strategy for select patients with small renal massesMarc C Smaldone, Robert G Uzzo
Urologic Oncology|May 6, 2009
Clinical implications of hypoxia inducible factor in renal cell carcinomaMarc C Smaldone, Jodi K Maranchie
Current Urology Reports|October 26, 2018
Performance Measurement and Quality Improvement Initiatives for Bladder Cancer CareBenjamin T Ristau, Marc C Smaldone
Current Opinion in Molecular Therapeutics|October 2, 2010
BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancersMarc C Smaldone, Benjamin J Davies
Pageof 25

Showing results (21-30 of 245) with videos related to

Sort By:
Pageof 25
Nature Reviews. Urology|March 15, 2017
Kidney cancer: Emerging guidelines for managing small renal massesBenjamin T Ristau, Marc C Smaldone
International Braz J Urol : Official Journal of the Brazilian Society of Urology|October 8, 2016
Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: NoBenjamin T Ristau, Marc C Smaldone
Urology|February 18, 2014
Editorial commentMarc C Smaldone, Robert G Uzzo
World Journal of Urology|May 13, 2008
Muscle derived stem cell therapy for stress urinary incontinenceMarc C Smaldone, Michael B Chancellor
Annals of Translational Medicine|October 29, 2019
Safety and delayed intervention rates of active surveillance for small renal masses in an elderly populationBrian T Kadow, Marc C Smaldone
Translational Andrology and Urology|June 23, 2021
Current controversies in minimally invasive urologic oncologyMarc C Smaldone, Jeffrey J Tomaszewski
Future Oncology (London, England)|October 14, 2011
Active surveillance: a potential strategy for select patients with small renal massesMarc C Smaldone, Robert G Uzzo
Urologic Oncology|May 6, 2009
Clinical implications of hypoxia inducible factor in renal cell carcinomaMarc C Smaldone, Jodi K Maranchie
Current Urology Reports|October 26, 2018
Performance Measurement and Quality Improvement Initiatives for Bladder Cancer CareBenjamin T Ristau, Marc C Smaldone
Current Opinion in Molecular Therapeutics|October 2, 2010
BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancersMarc C Smaldone, Benjamin J Davies
Pageof 25